Becker's Healthcare January 24, 2025
Alexandra Murphy

AbbVie has entered a collaboration with Neomorph to develop molecular glue degraders for oncology and immunology.

Molecular glue degraders are a class of small molecules designed to selectively degrade proteins that contribute to disease, including those involved in cancer growth and immune system dysfunction, according to a Jan. 23 news release from the drugmaker.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
People on Ozempic may have fewer heart attacks, strokes, addictions—but more nausea, vomiting, stomach pain
Exploring the Future of Genomics and Life Sciences
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Novo Nordisk Obesity Drug Shows 22% Weight Loss, But Lack of Safety Detail Is a Sticking Point
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks

Share This Article